CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.120

-4.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ProZapper who wrote (170)	9/20/1998 10:02:00 PM
From: david wolf	Read Replies (1) of 668

Thread's kind of quiet??? Stopped by the library and pulled latest update on CBMI from Sturza Newsletter; here are some highlights ... "We believe Stryker will complete its PMA submission in November, resulting in an FDA Advisory Panel meeting in Q199." "At current prices, the market is valuing CMBI's OP-1 technology at $49M, an extremely low valuation considering that there are 400,000 bone graft procedures performed in the U.S. annually, which OP-1 could potentially replace." "We believe investor interest in these shares will rebound over the next six months, with completion of the PMA filing and the scheduling of a FDA ADvisory Panel meeting." "We reiterate our STRONG BUY recommendation; our one-year target is $12."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next